These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 28601309

  • 1. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
    Megna BW, Carney PR, Depke MG, Nukaya M, McNally J, Larsen L, Rosengren RJ, Kennedy GD.
    J Surg Res; 2017 Jun 01; 213():16-24. PubMed ID: 28601309
    [Abstract] [Full Text] [Related]

  • 2. Indole-3-carbinol induces tumor cell death: function follows form.
    Megna BW, Carney PR, Nukaya M, Geiger P, Kennedy GD.
    J Surg Res; 2016 Jul 01; 204(1):47-54. PubMed ID: 27451867
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer.
    Rajitha B, Nagaraju GP, Shaib WL, Alese OB, Snyder JP, Shoji M, Pattnaik S, Alam A, El-Rayes BF.
    Mol Carcinog; 2017 Jan 01; 56(1):288-299. PubMed ID: 27128654
    [Abstract] [Full Text] [Related]

  • 5. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
    Yadav B, Taurin S, Larsen L, Rosengren RJ.
    Int J Oncol; 2012 Nov 01; 41(5):1723-32. PubMed ID: 22971638
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
    Zhu S, Moore TW, Morii N, Howard RB, Culver D, Arrendale RF, Reddy P, Evers TJ, Zhang H, Sica G, Chen ZG, Sun A, Fu H, Khuri FR, Shin DM, Snyder JP, Shoji M.
    Curr Cancer Drug Targets; 2014 Nov 01; 14(4):380-93. PubMed ID: 24628271
    [Abstract] [Full Text] [Related]

  • 8. Antiproliferative Effect of a Novel 4,4'-Disulfonyldiarylidenyl Piperidone in Human Colon Cancer Cells.
    Prabhat AM, Kuppusamy ML, Bognár B, Kálai T, Hideg K, Kuppusamy P.
    Cell Biochem Biophys; 2019 Mar 01; 77(1):61-67. PubMed ID: 30552554
    [Abstract] [Full Text] [Related]

  • 9. Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
    He G, Feng C, Vinothkumar R, Chen W, Dai X, Chen X, Ye Q, Qiu C, Zhou H, Wang Y, Liang G, Xie Y, Wu W.
    Cancer Chemother Pharmacol; 2016 Dec 01; 78(6):1151-1161. PubMed ID: 27787644
    [Abstract] [Full Text] [Related]

  • 10. Effects of human blood levels of two PAH mixtures on the AHR signalling activation pathway and CYP1A1 and COMT target genes in granulosa non-tumor and granulosa tumor cell lines.
    Zajda K, Ptak A, Rak A, Fiedor E, Grochowalski A, Milewicz T, Gregoraszczuk EL.
    Toxicology; 2017 Aug 15; 389():1-12. PubMed ID: 28710019
    [Abstract] [Full Text] [Related]

  • 11. Chromatin remodeling by curcumin alters endogenous aryl hydrocarbon receptor signaling.
    Mohammadi-Bardbori A, Akbarizadeh AR, Delju F, Rannug A.
    Chem Biol Interact; 2016 May 25; 252():19-27. PubMed ID: 27041069
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aryl hydrocarbon receptor activation by aminoflavone: new molecular target for renal cancer treatment.
    Callero MA, Suárez GV, Luzzani G, Itkin B, Nguyen B, Loaiza-Perez AI.
    Int J Oncol; 2012 Jul 25; 41(1):125-34. PubMed ID: 22485252
    [Abstract] [Full Text] [Related]

  • 16. Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells.
    Ronnekleiv-Kelly SM, Nukaya M, Díaz-Díaz CJ, Megna BW, Carney PR, Geiger PG, Kennedy GD.
    Cancer Lett; 2016 Jan 01; 370(1):91-9. PubMed ID: 26515162
    [Abstract] [Full Text] [Related]

  • 17. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
    Al-Qasem A, Al-Howail HA, Al-Swailem M, Al-Mazrou A, Al-Otaibi B, Al-Jammaz I, Al-Khalaf HH, Aboussekhra A.
    Mol Carcinog; 2016 Mar 01; 55(3):233-44. PubMed ID: 25641341
    [Abstract] [Full Text] [Related]

  • 18. Aryl hydrocarbon receptor, a tumor grade‑associated marker of oral cancer, is directly downregulated by polydatin: A pilot study.
    Martano M, Stiuso P, Facchiano A, De Maria S, Vanacore D, Restucci B, Rubini C, Caraglia M, Ravagnan G, Lo Muzio L.
    Oncol Rep; 2018 Sep 01; 40(3):1435-1442. PubMed ID: 30015848
    [Abstract] [Full Text] [Related]

  • 19. The arylhydrocarbon receptor is only marginally involved in the antileukemic effects of its ligand curcumin.
    Goergens A, Frericks M, Esser C.
    Anticancer Res; 2009 Nov 01; 29(11):4657-64. PubMed ID: 20032417
    [Abstract] [Full Text] [Related]

  • 20. Mixed-ligand copper(II) complexes activate aryl hydrocarbon receptor AhR and induce CYP1A genes expression in human hepatocytes and human cell lines.
    Kubešová K, Dořičáková A, Trávníček Z, Dvořák Z.
    Toxicol Lett; 2016 Jul 25; 255():24-35. PubMed ID: 27180721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.